Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. I… Read more
Virbac SA (VRBCF) - Total Assets
Latest total assets as of June 2025: $1.82 Billion USD
Based on the latest financial reports, Virbac SA (VRBCF) holds total assets worth $1.82 Billion USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Virbac SA - Total Assets Trend (2002–2024)
This chart illustrates how Virbac SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Virbac SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Virbac SA's total assets of $1.82 Billion consist of 45.7% current assets and 54.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.1% |
| Accounts Receivable | $255.50 Million | 13.8% |
| Inventory | $404.17 Million | 21.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $251.24 Million | 13.6% |
| Goodwill | $276.63 Million | 15.0% |
Asset Composition Trend (2002–2024)
This chart illustrates how Virbac SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Virbac SA's current assets represent 45.7% of total assets in 2024, a decrease from 62.9% in 2002.
- Cash Position: Cash and equivalents constituted 8.1% of total assets in 2024, up from 0.0% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 9.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 21.9% of total assets.
Virbac SA Competitors by Total Assets
Key competitors of Virbac SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
|
Zhejiang Zhenyuan Share Co Ltd
SHE:000705
|
China | CN¥3.03 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
China | CN¥2.58 Billion |
|
Zhejiang Haisen Pharmaceutical Co. Ltd. A
SHE:001367
|
China | CN¥1.52 Billion |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019
|
China | CN¥13.11 Billion |
|
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198
|
China | CN¥774.73 Million |
|
PharmGen Science Inc
KO:004720
|
Korea | ₩331.46 Billion |
Virbac SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Virbac SA generates 0.76x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Virbac SA generates $7.86 in net profit.
Virbac SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.96 | 1.65 | 2.28 |
| Quick Ratio | 1.04 | 0.89 | 1.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $411.65 Million | $ 346.67 Million | $ 443.14 Million |
Virbac SA - Advanced Valuation Insights
This section examines the relationship between Virbac SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.37 |
| Latest Market Cap to Assets Ratio | 0.72 |
| Asset Growth Rate (YoY) | 27.0% |
| Total Assets | $1.85 Billion |
| Market Capitalization | $1.34 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Virbac SA's assets below their book value (0.72 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Virbac SA's assets grew by 27.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Virbac SA (2002–2024)
The table below shows the annual total assets of Virbac SA from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $1.85 Billion | +26.98% |
| 2023-12-31 | $1.46 Billion | +9.17% |
| 2022-12-31 | $1.33 Billion | +10.98% |
| 2021-12-31 | $1.20 Billion | +8.11% |
| 2020-12-31 | $1.11 Billion | -16.01% |
| 2019-12-31 | $1.32 Billion | +3.96% |
| 2018-12-31 | $1.27 Billion | -0.35% |
| 2017-12-31 | $1.28 Billion | -9.87% |
| 2016-12-31 | $1.42 Billion | -0.94% |
| 2015-12-31 | $1.43 Billion | +7.90% |
| 2014-12-31 | $1.33 Billion | +47.94% |
| 2013-12-31 | $896.23 Million | +8.28% |
| 2012-12-31 | $827.70 Million | +40.61% |
| 2011-12-31 | $588.63 Million | +10.28% |
| 2010-12-31 | $533.75 Million | +22.85% |
| 2009-12-31 | $434.47 Million | +5.29% |
| 2008-12-31 | $412.66 Million | +9.56% |
| 2007-12-31 | $376.64 Million | -0.59% |
| 2006-12-31 | $378.87 Million | +20.53% |
| 2005-12-31 | $314.32 Million | +6.86% |
| 2004-12-31 | $294.13 Million | +3.09% |
| 2003-12-31 | $285.31 Million | +6.96% |
| 2002-12-31 | $266.74 Million | -- |